AbbVie Results Reflect Humira Hit In Q3

US Sales Down By Almost Two-Fifths As Adalimumab Biosimilar Competition Bites

 
• By David Wallace
  
Arrows down (Zoonar GmbH/Alamy Stock Photo)
Humira sales took a hit in Q3 (Zoonar GmbH / Alamy Stock Photo/Alamy Stock Photo)
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products